Veru IncNASDAQ:VERUNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.7337
- TODAY'S CHANGE (%)-0.0298 (-3.9031%)
- Bid / Lots0.7233/ 1
- Ask / Lots0.7500/ 23
- Open / Previous Close0.7511 / 0.7635
- Day Range
- 52 Week Range
- Volume410,871
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VERU |
|---|---|---|
| 09:32 ET | 7044 | 0.755 |
| 09:33 ET | 367 | 0.75 |
| 09:35 ET | 4328 | 0.747 |
| 09:37 ET | 300 | 0.747 |
| 09:42 ET | 1300 | 0.7506 |
| 09:44 ET | 842 | 0.7426 |
| 09:46 ET | 200 | 0.7512 |
| 09:48 ET | 632 | 0.7547 |
| 09:50 ET | 5145 | 0.7507 |
| 09:55 ET | 471 | 0.7453 |
| 09:57 ET | 100 | 0.7578 |
| 10:00 ET | 302 | 0.7525 |
| 10:06 ET | 100 | 0.7578 |
| 10:08 ET | 3000 | 0.755899 |
| 10:09 ET | 652 | 0.7578 |
| 10:13 ET | 1894 | 0.7638 |
| 10:20 ET | 1315 | 0.7642 |
| 10:24 ET | 2652 | 0.7579 |
| 10:26 ET | 1898 | 0.76 |
| 10:27 ET | 1203 | 0.76 |
| 10:29 ET | 3375 | 0.75915 |
| 10:31 ET | 300 | 0.75915 |
| 10:33 ET | 2100 | 0.76 |
| 10:38 ET | 916 | 0.76 |
| 10:40 ET | 1362 | 0.7598 |
| 10:42 ET | 491 | 0.76 |
| 10:47 ET | 23458 | 0.76 |
| 10:49 ET | 7762 | 0.76 |
| 10:51 ET | 5576 | 0.76 |
| 10:54 ET | 4200 | 0.76 |
| 10:56 ET | 900 | 0.75955 |
| 10:58 ET | 753 | 0.759 |
| 11:00 ET | 300 | 0.758 |
| 11:02 ET | 200 | 0.758 |
| 11:03 ET | 1250 | 0.76 |
| 11:05 ET | 800 | 0.758 |
| 11:07 ET | 4300 | 0.759 |
| 11:09 ET | 1500 | 0.758 |
| 11:12 ET | 100 | 0.758 |
| 11:14 ET | 655 | 0.76 |
| 11:16 ET | 300 | 0.758 |
| 11:18 ET | 200 | 0.758 |
| 11:20 ET | 800 | 0.758 |
| 11:21 ET | 1972 | 0.759999 |
| 11:23 ET | 200 | 0.758 |
| 11:25 ET | 500 | 0.758 |
| 11:27 ET | 542 | 0.758 |
| 11:30 ET | 580 | 0.758 |
| 11:32 ET | 300 | 0.758 |
| 11:34 ET | 200 | 0.758 |
| 11:36 ET | 200 | 0.7579 |
| 11:38 ET | 3115 | 0.758 |
| 11:39 ET | 18029 | 0.7577 |
| 11:41 ET | 350 | 0.758799 |
| 11:43 ET | 200 | 0.7523 |
| 11:48 ET | 1600 | 0.7588 |
| 11:56 ET | 100 | 0.7502 |
| 11:59 ET | 600 | 0.7501 |
| 12:01 ET | 2200 | 0.7565 |
| 12:03 ET | 100 | 0.7504 |
| 12:08 ET | 200 | 0.7504 |
| 12:10 ET | 100 | 0.7504 |
| 12:14 ET | 100 | 0.7504 |
| 12:15 ET | 300 | 0.7504 |
| 12:17 ET | 200 | 0.7504 |
| 12:19 ET | 1214 | 0.7564 |
| 12:24 ET | 828 | 0.757 |
| 12:26 ET | 100 | 0.7575 |
| 12:30 ET | 663 | 0.76 |
| 12:32 ET | 300 | 0.7576 |
| 12:33 ET | 902 | 0.76 |
| 12:35 ET | 1676 | 0.7588 |
| 12:37 ET | 231 | 0.7576 |
| 12:39 ET | 1946 | 0.7529 |
| 12:42 ET | 399 | 0.7543 |
| 12:46 ET | 200 | 0.7543 |
| 12:50 ET | 1370 | 0.7546 |
| 12:51 ET | 2800 | 0.7546 |
| 12:55 ET | 400 | 0.76 |
| 12:57 ET | 3891 | 0.7573 |
| 01:00 ET | 2355 | 0.754701 |
| 01:02 ET | 7799 | 0.75 |
| 01:08 ET | 337 | 0.75 |
| 01:09 ET | 300 | 0.7494 |
| 01:11 ET | 312 | 0.7494 |
| 01:13 ET | 400 | 0.7454 |
| 01:15 ET | 100 | 0.7456 |
| 01:20 ET | 300 | 0.7456 |
| 01:22 ET | 5000 | 0.7495 |
| 01:24 ET | 100 | 0.7456 |
| 01:26 ET | 100 | 0.7456 |
| 01:27 ET | 100 | 0.7456 |
| 01:29 ET | 1353 | 0.74885 |
| 01:31 ET | 200 | 0.7495 |
| 01:33 ET | 400 | 0.7489 |
| 01:36 ET | 800 | 0.7489 |
| 01:38 ET | 336 | 0.7489 |
| 01:42 ET | 3000 | 0.7475 |
| 01:44 ET | 200 | 0.7449 |
| 01:45 ET | 300 | 0.7449 |
| 01:47 ET | 100 | 0.7449 |
| 01:49 ET | 100 | 0.7449 |
| 01:51 ET | 313 | 0.7438 |
| 01:54 ET | 400 | 0.7438 |
| 01:56 ET | 2500 | 0.7455 |
| 01:58 ET | 684 | 0.7455 |
| 02:00 ET | 1145 | 0.7455 |
| 02:02 ET | 1595 | 0.7413 |
| 02:03 ET | 400 | 0.7401 |
| 02:05 ET | 200 | 0.7445 |
| 02:07 ET | 530 | 0.7445 |
| 02:09 ET | 800 | 0.7445 |
| 02:12 ET | 231 | 0.74245 |
| 02:14 ET | 184 | 0.7404 |
| 02:16 ET | 100 | 0.7404 |
| 02:18 ET | 900 | 0.7406 |
| 02:20 ET | 1700 | 0.742 |
| 02:21 ET | 1600 | 0.7408 |
| 02:23 ET | 2595 | 0.7408 |
| 02:25 ET | 100 | 0.7434 |
| 02:27 ET | 100 | 0.7434 |
| 02:32 ET | 600 | 0.74559 |
| 02:34 ET | 600 | 0.7456 |
| 02:36 ET | 494 | 0.7434 |
| 02:38 ET | 300 | 0.7434 |
| 02:39 ET | 231 | 0.746 |
| 02:41 ET | 600 | 0.7414 |
| 02:45 ET | 100 | 0.7409 |
| 02:48 ET | 18290 | 0.7409 |
| 02:50 ET | 3372 | 0.7405 |
| 02:52 ET | 3800 | 0.7414 |
| 02:56 ET | 200 | 0.7428 |
| 02:57 ET | 500 | 0.7414 |
| 02:59 ET | 3024 | 0.74 |
| 03:01 ET | 11604 | 0.74 |
| 03:03 ET | 400 | 0.74 |
| 03:06 ET | 300 | 0.74 |
| 03:08 ET | 700 | 0.7356 |
| 03:10 ET | 1090 | 0.7356 |
| 03:12 ET | 1144 | 0.7355 |
| 03:14 ET | 500 | 0.7351 |
| 03:15 ET | 5486 | 0.7301 |
| 03:17 ET | 9567 | 0.7302 |
| 03:19 ET | 4900 | 0.7302 |
| 03:21 ET | 199 | 0.7347 |
| 03:26 ET | 1654 | 0.7315 |
| 03:28 ET | 600 | 0.7315 |
| 03:30 ET | 1724 | 0.7315 |
| 03:32 ET | 1366 | 0.73879 |
| 03:33 ET | 300 | 0.7315 |
| 03:35 ET | 200 | 0.7315 |
| 03:37 ET | 25787 | 0.7301 |
| 03:39 ET | 4071 | 0.7303 |
| 03:42 ET | 1300 | 0.7303 |
| 03:44 ET | 2862 | 0.7332 |
| 03:48 ET | 600 | 0.7356 |
| 03:50 ET | 9028 | 0.7351 |
| 03:51 ET | 7294 | 0.7311 |
| 03:53 ET | 17785 | 0.73405 |
| 03:55 ET | 3100 | 0.736 |
| 03:57 ET | 2296 | 0.7307 |
| 04:00 ET | 45457 | 0.7337 |
Oct 21, 2024
Oct 16, 2024
Veru to Deliver Keynote Presentation on the Scientific Support for Enobosarm in Combination with GLP-1 Receptor Agonist to Preserve Muscle for Higher Quality Weight Loss at the 4th Edition of the World Obesity and Weight Management Congress, from 8:30AM ET on Wednesday Oct 16, 2024 by Dow Jones
8:30AM ET on Wednesday Oct 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Veru Inc | 111.8M | -2.1x | --- |
Unicharm Corp | 19.5B | 31.3x | +7.47% |
Stephan Co | 4.2M | -0.5x | --- |
AXIL Brands Inc | 30.1M | 18.3x | --- |
CCA Industries Inc | 5.9M | -25.3x | --- |
Nextera Enterprises Inc | 40.0 | 0.0x | --- |
Company Information
Veru Inc. is a biopharmaceutical company. The Company is focused on developing medicines for the for the treatment of hospitalized COVID-19 patients at high risk for acute respiratory distress syndrome (ARDS) and other viral-related ARDS and for the management of breast and prostate cancers. The Company offers two FDA approved products within its sexual health program, including ENTADFI (tadalafil 5mg and finasteride 5mg capsule), for the treatment of benign prostatic hyperplasia and FC2 Female Condom (internal condom) (FC2), for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. Its breast cancer drug pipeline has four clinical development programs for two drugs, such as enobosarm, an oral selective androgen receptor targeting agonist, and sabizabulin, an oral cytoskeleton disruptor. Its prostate cancer drug pipeline includes sabizabulin, VERU-100 and zuclomiphene citrate.
Contact Information
- Headquarters
- 2916 N. MIAMI AVENUE, SUITE 1000MIAMI, FL, United States 33127
- Phone
- 312-595-9123
- Fax
- 312-595-9122
Executives
- Chairman of the Board, President, Chief Executive Officer
- Mitchell Steiner
- Chief Corporate Officer, Director
- Harry Fisch
- Chief Financial Officer, Chief Administrative Officer
- Michele Greco
- Chief Scientific Officer
- K. Gary Barnette
- Independent Director
- Mario Eisenberger
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $111.8M |
|---|---|
Revenue (TTM) | $14.1M |
Shares Outstanding | 146.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.47 |
EPS | $-0.35 |
Book Value | $0.21 |
P/E Ratio | -2.1x |
Price/Sales (TTM) | 7.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -281.09% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
